Semaglutide and tirzepatide Popular weight loss peptides semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) work in similar ways to support weight loss, notes Hanouneh
Melanotan I + BPC-157 Combines pigmentation signaling with cutaneous repair and tissue regeneration research
The Ozempic vision loss lawsuit involves claims that semaglutide medications, including Ozempic, Wegovy, and Rybelsus, may be associated with non-arteritic anterior ischemic optic neuropathy (NAION), a rare optic nerve condition that can cause sudden, permanent vision loss
Deficiency is particularly common in elderly people, because the ability to absorb vitamin B12 can decrease with age
These tests arent just busywork
After taking 2.4mg of Wegovy over 68 weeks, the average weight lost was 17.5% from starting weight